Scholars Central

CommentaryPublished 21 May 2021

Detecting Lupus Nephritis

Authors: De Rosa Marcelo, Brad H. Rovin, Salem Almaan

Lupus: Open Access

Volume 6 · Issue 4 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cutaneous Lupus Erythematosus (CLE) is an autoimmune disease that encompasses a wide range of dermatologic manifestations with varying degrees of association with systemic disease. Treatment options for CLE are limited, and no medication has been approved specifically for CLE. However, increased emphasis on the role of biological therapies for CLE has emerged in recent years due to an improved understanding of the pathogenesis of CLE. This review summarizes the recent insights into the pathogenesis of CLE and current advances in the development of CLE treatments.

Subjects

Rheumatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Lupus: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalLupus: Open Access
  • SubjectRheumatology
  • BylineArticles whose byline prints “De Rosa Marcelo”
  • BylineArticles whose byline prints “Brad H. Rovin”
  • BylineArticles whose byline prints “Salem Almaan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels